https://www.maxlifeinsurance.com/about-us/board-of-directors

• Notice of the 103rd Statutory Board Meeting_October 19, 2022_Max Life
  
• Notice of 102nd Statutory Board Meeting_Aug 1, 2022_Max Life
• Notice for the 101st Statutory Board Meeting_May 10, 2022_Max Life
• Notice for the 100th Board Meeting Jan 28 2022 Approval of Financials QE Dec 2021
• Notice of 99th Board Meeting - Nov 9, 2021 - Approval of Financials QE Sept, 2021
• Notice of the 97th Statutory Board Meeting_August 10, 2021_Max Life

Annual Return_FY_2021-22

• AuditedFinancialResultsAndSecurityCover_Dec312022_MaxLife_NSEDisclosure
• IntimationToNSE_Reg50_SEBILODR_MaxLife_January232023
• Compliance Certificate_Regulation 3(5) 3(6)_SEBI (PIT) Regulations_December 31 2022
• SubmissionOfRestatedAOAToNSE_January92023
• IntimationToNSE_Reg51(2)_SEBILODR_MaxLife_January2023
• DisclosureUnderReg7oftheSEBILODRMaxLifeQEDecember312022
• DisclosureUnderReg6oftheSEBILODRMaxLifeDecember312022
• StatementOfInvestorGrievances_MaxLife_December312022
• IntimationtoNSE_TransferStakeOfMaxLifeByMSItoMFSL_Nov282022
• DisclosureUnder54(3)_Max Life
• NewspapaerPublicationOfQ2FY23Results_MaxLife
• AuditedFinancialResults_September302022_MaxLife_SEBILODR
• IntimationtoNSE_Reg50_SEBILODR_MaxLife_September2022
• Compliance Certificate_Regulation 3(5), 3(6)_SEBI (PIT) Regulations 2015_18.11.2022
• DisclosureUnderReg6and7oftheSEBILODRMaxLife_QESeptember302022
• StatementOfInvestorGrievances_MaxLife_September302022
• StatementUnderSEBINCSOperationCircularMaxLifeSeptember302022_Revised
• CertificateUnder57(5)_SEBILODR2015_MaxLife_Revised
• IntimationtoNSE_PressReleaseRegardingReceiptOfCOBbyMLPFM_MaxLife
• NewspaperPublicationOfQ1FY23Results_MaxLife
• CertificateOfInterestPaymentUnderReg57(1)_SEBILODR_MaxLife
• QuarterlyAuditedFinancialResults_QE30June2022_MaxLife
• SubmissionToNSE_Para2_ChapterXIVofNCSoperationalframework_MaxLife
  
• IntimationToNSE_Reg50_SEBILODR_MaxLife_June2022
  
• DisclosureUnderReg6and7oftheSEBILODRMaxLife_QE_june30_2022
  
• StatementOfInvestorGrievances_MaxLife_June302022
  
• IntimationtoNSEunderRegulation60(2)ofSEBILODR_MaxLife
  
• IntimationtoNSEunderRegulation57(4)OfSEBILODR_MaxLife
  
• NewspaperPublicationOfQ4AndFY22Results_MaxLife
• AssetCoverUnder54_MaxLife
  
• AuditedFinancialResults_March312022_MaxLife_SEBILODR
  
• AnnualReport_Reg53(2)_SEBILODR_MaxLife_10May2022
• IntimationToNSE_Reg51(2)_SEBILODR_MaxLife_May2022
• IntimationToNSE_Reg50(1)_SEBILODR_MaxLife_May2022
  
• IntimationToNSE_Reg50(2)_SEBILODR_MaxLife_May2022
  
• Initial Disclosure to NSE_LC_SEBI circular dated Nov 26, 2018
  
• Compliance Certificate Under Clause7(3)ofSEBILODR_MaxLife
  
• Disclosure Under Reg6and7 of the SEBILODR_MaxLife
  
• StatementOfInvestorGrievances_Max Life_March312022
  
• StatementUnderSEBINCSOperationCircularMaxLifeMarch312022
  
• IntimationtoNSEForResignationofDyChiefFinancialOfficerMaxLife
• Intimation to NSE_Para 9.1 of Chapter XI of NCS operational framework_Ma
• IntimationForIncorporationOfWhollyOwnedSubsdiary
• Intimation To NSE_Reg50 SEBI LODR MaxLife January 28-01-2022
• Quarterly Financial Results December-31-2021 MaxLife
  
• Newspaper Publication Of Q3 FY22 Results MaxLife
  
• Intimation to NSE Regarding Reg6and7 of SEBI LODR MaxLife December-2021
• Statement of Investor Grievances MaxLife December 31 2021
• Certificate on Asset Coverage Ratio_September 30, 2021
• Intimation to NSE_Reg 6 and 7_SEBI LODR_MaxLife
• Intimation to NSE_Reg50_SEBI LODR_MaxLife_Nov 2, 2021
• Newspaper publication of Q2FY22 Results_MaxLife
• Statement for Utilisation of Proceeds_MaxLife_Sept 30, 2021
• Statement of Investor grievances_MaxLife_Sept 30, 2021
• Statement under SEBI circular dated August 10, 2021

Subordinated Debt Rating

Credit rating of subordinated debt reflects the degree of safety regarding timely servicing of financial obligations.

For investor grievances, please contact:

Anurag Chauhan

Company Secretary and Compliance Officer

Email: investorgrievance@maxlifeinsurance.com

Telephone: +91 124 412 1500

IDBI Trusteeship Services Limited

Address: Asian Building, Ground Floor,

17 R. Kamani Marg, Ballard Estate

Mumbai- 400 001

Phone: 022 40807000

Email: itsl@idbitrustee.com   

Website:  www.idbitrustee.com